In vitro validation: GLY alleviates UV-induced corneal epithelial damage through the HMGB1-TLR/MyD88-NF-κB signaling pathway

Acta Histochem. 2023 Dec;125(8):152111. doi: 10.1016/j.acthis.2023.152111. Epub 2023 Nov 6.

Abstract

UV-induced corneal damage is a common ocular surface injury that usually leads to corneal lesions causing persistent inflammation. High mobility group box 1 (HMGB1) is identified as an inflammatory alarm in various tissue injuries. Here, this study first evaluates the repair effect of the HMGB1-selective inhibitor GLY in UV-induced corneal damage; Secondly, the inhibitory effect of GLY on UV-induced corneal damage induced inflammation and the potential therapeutic mechanism of GLY were studied. GLY effectively attenuates the expression of UV-induced inflammatory factors and HMGB1, TLR/MyD88, NF-κB signaling pathway genes at the mRNA and protein levels. In addition, RT-PCR and Western Blot experiments after knocking down HMGB1 and TLR2/9 genes showed that GLY alleviated corneal inflammation by inhibiting the HMGB1-TLR/MyD88 signaling pathway. The results of this study show that targeting HMGB1-NF-κB by GLY can alleviate the inflammatory response induced by UV induction.

Keywords: Corneal epithelial cells; GLY; HMGB1; Inflammation; UV.

MeSH terms

  • Corneal Injuries* / complications
  • HMGB1 Protein* / genetics
  • HMGB1 Protein* / metabolism
  • Humans
  • Inflammation / metabolism
  • Myeloid Differentiation Factor 88 / genetics
  • Myeloid Differentiation Factor 88 / metabolism
  • Myeloid Differentiation Factor 88 / pharmacology
  • NF-kappa B / metabolism
  • Signal Transduction
  • Ultraviolet Rays* / adverse effects

Substances

  • HMGB1 Protein
  • Myeloid Differentiation Factor 88
  • NF-kappa B